Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Open accessThe DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The interrogation of proteomes ("proteomics") in a highly multiplexed and efficient manner remains a coveted and challenging goal in biology and medicine. METHODOLOGY/PRINCIPAL FINDINGS: We present a new aptamer-based proteomic technology for biomarker discovery capable of simultaneously measuring thousands of proteins from small sample volumes (15 µL of serum or plasma). Our current assay measures 813 proteins with low limits of detection (1 pM median), 7 logs of overall dynamic range (~100 fM-1 µM), and 5% median coefficient of variation. This technology is enabled by a new generation of aptamers that contain chemically modified nucleotides, which greatly expand the physicochemical diversity of the large randomized nucleic acid libraries from which the aptamers are selected. Proteins in complex matrices such as plasma are measured with a process that transforms a signature of protein concentrations into a corresponding signature of DNA aptamer concentrations, which is quantified on a DNA microarray. Our assay takes advantage of the dual nature of aptamers as both folded protein-binding entities with defined shapes and unique nucleotide sequences recognizable by specific hybridization probes. To demonstrate the utility of our proteomics biomarker discovery technology, we applied it to a clinical study of chronic kidney disease (CKD). We identified two well known CKD biomarkers as well as an additional 58 potential CKD biomarkers. These results demonstrate the potential utility of our technology to rapidly discover unique protein signatures characteristic of various disease states. CONCLUSIONS/SIGNIFICANCE: We describe a versatile and powerful tool that allows large-scale comparison of proteome profiles among discrete populations. This unbiased and highly multiplexed search engine will enable the discovery of novel biomarkers in a manner that is unencumbered by our incomplete knowledge of biology, thereby helping to advance the next generation of evidence-based medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Major developments in mass spectrometry-based, antibody-based and aptamer-based proteomics over the past decade have enabled the robust quantification of thousands of proteins in single samples87–90.”
From Measuring biological age using omics data (2022) · cites this paper as [89]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The assay uses DNA-based slow off-rate modified aptamers (SOMAmerTM reagents) to quantify the relative abundance of approximately 7000 proteins with high specificity and limits of detection largely comparable to antibody-based assays.”
From Cross-ancestry comparison of aptamer and antibody protein measures (2026) · cites this paper as [53]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Proteomic technologies, including mass spectrometry–based proteomics, aptamer-based arrays (SomaLogic), and proximity extension assay technology (Olink), are now available for the large-scale quantification and validation of thousands of proteins in human biological fluids or tissues (122–127).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RNA-Mediated Metal-Metal Bond Formation in the Synthesis of Hexagonal Palladium Nanoparticles
Gugliotti, L. A., Feldheim, D. L., & Eaton, B. E. (2004) · Science · doi:10.1126/science.1095678 · Cited by 197 · cited 2×
“This innovation was used to select catalysts, including the first RNA-catalyzed carbon-carbon bond formation [16,23].”
MethodSelf-citationRetractedLevey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405 · cited 4×
“Based on the collective knowledge of the aptamer field that has developed since its inception [13,14], we hypothesized that aptamers could make exceptional reagents for high-content proteomics.”
BackgroundInfluentialSelf-citationIn vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812 · cited 4×
“Based on the collective knowledge of the aptamer field that has developed since its inception [13,14], we hypothesized that aptamers could make exceptional reagents for high-content proteomics.”
BackgroundInfluentialKeller, A., Nesvizhskii, A. I., Kolker, E., & Aebersold, R. (2002) · Analytical Chemistry · doi:10.1021/ac025747h · Cited by 4,830 · cited 2×
“0% probability as specified by the Peptide Prophet algorithm [45].”
MethodA Statistical Model for Identifying Proteins by Tandem Mass Spectrometry
Nesvizhskii, A. I., Keller, A., Kolker, E., & Aebersold, R. (2003) · Analytical Chemistry · doi:10.1021/ac0341261 · Cited by 4,809 · cited 3×
“Protein probabilities were assigned by the Protein Prophet algorithm [44].”
MethodAssessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952 · cited 2×
“Eleven subjects had early-stage CKD based on estimated GFR (Table 3) (eGFR, defined as stages 1–2, median creatinine clearance 70 ml/min/m, range 62–97 ml/min/m) and 31 had late-stage CKD (stages 3–5, median creatinine clearance 25 ml/min/m, range 7–49 ml/min/m) [33].”
BackgroundPegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337 · cited 1×
“Aptamers are a class of nucleic acid-based molecules discovered twenty years ago [13,14] and have since been employed in diverse applications including therapeutics [15], catalysis [16], and now proteomics.”
BackgroundHopfield, J. J. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.10.4135 · Cited by 1,594 · cited 2×
“Inspired by classic kinetic theory of specific binding in complex mixtures [25,26], we employed kinetic manipulations to help overcome the problem of non-specific SOMAmer-protein binding.”
MethodLevey, A. S., Atkins, R., Coresh, J., Cohen, E. P., Collins, A. J., Eckardt, K.-U., Nahas, M. E., Jaber, B. L., Jadoul, M., Levin, A., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002343 · Cited by 1,516 · cited 4×
“CKD biomarkers could also be useful for monitoring disease progression and guiding treatment [28–31].”
BackgroundInfluential
Cited by
Items 301–400 of 1,009
Tracking disease progression non‐invasively in Duchenne and Becker muscular dystrophies
Spitali, P., Hettne, K. M., Tsonaka, R., Charrout, M., van den Bergen, J. C., Koeks, Z., Kan, H. E., Hooijmans, M. T., Roos, A., Straub, V. W., et al. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12304 · Cited by 81
High-content affinity-based proteomics: unlocking protein biomarker discovery
Brody, E. N., Gold, L., Lawn, R. M., Walker, J. J., & Zichi, D. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.89 · Cited by 80
Self-citationRay, P., Rialon-Guevara, K. L., Veras, E. F. T., Sullenger, B. A., & White, R. R. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62385 · Cited by 81
Lindbohm, J. V., Mars, N., Walker, K. A., Singh‐Manoux, A., Livingston, G., Brunner, E. J., Sipilä, P. N., Saksela, K., Ferrie, J. E., Lovering, R. C., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12419 · Cited by 70
Replacing antibodies with modified DNA aptamers in vaccine potency assays
Trausch, J. J., Shank-Retzlaff, M. L., & Verch, T. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.04.003 · Cited by 70
Deciphering the Plasma Proteome of Type 2 Diabetes
Elhadad, M. A., Jonasson, C., Huth, C., Wilson, R., Gieger, C., Matías‐García, P. R., Grallert, H., Graumann, J., Gailus‐Durner, V., Rathmann, W., et al. (2020) · Diabetes · doi:10.2337/db20-0296 · Cited by 80
RNA Aptamers: A Review of Recent Trends and Applications
Kang, K.-N., & Lee, Y. (2012) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2012_136 · Cited by 84
Wang, Y., Rauf, S., Grewal, Y. S., Spadafora, L. J., Shiddiky, M. J. A., Cangelosi, G. A., Schlücker, S., & Trau, M. (2014) · Analytical Chemistry · doi:10.1021/ac5027012 · Cited by 69
Molecular affinity rulers: systematic evaluation of DNA aptamers for their applicabilities in ELISA
Kimoto, M., Lim, Y. W. S., & Hirao, I. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz688 · Cited by 70
Highly Multiplexed Proteomic Platform for Biomarker Discovery, Diagnostics, and Therapeutics
Mehan, M. R., Ostroff, R. M., Wilcox, S. K., Steele, F. R., Schneider, D. J., Jarvis, T. C., Baird, G. S., Gold, L., & Janjić, N. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4118-2_20 · Cited by 69
Self-citationUsing Aptamers for Cancer Biomarker Discovery
Chang, Y. M., Donovan, M. J., & Tan, W. (2013) · Journal of Nucleic Acids · doi:10.1155/2013/817350 · Cited by 76
Enhancing aptamer function and stability via in vitro selection using modified nucleic acids
Meek, K. N., Rangel, A. E., & Heemstra, J. M. (2016) · Methods · doi:10.1016/j.ymeth.2016.03.008 · Cited by 71
Graumann, J., Finkernagel, F., Reinartz, S., Stief, T., Brödje, D., Renz, H., Jansen, J. M., Wagner, U., Worzfeld, T., Pogge von Strandmann, E., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01150 · Cited by 67
Timsina, J., Gomez-Fonseca, D., Wang, L., Do, A., Western, D., Alvarez, I., Aguilar, M., Pastor, P., Henson, R. L., Herries, E., et al. (2022) · Journal of Alzheimer’s Disease · doi:10.3233/jad-220399 · Cited by 68
“The scalable nature of these aptamers also allows for addition of new targets as more human proteins are discovered [7].”
InfluentialA proteogenomic view of Parkinson’s disease causality and heterogeneity
Kaiser, S., Zhang, L., Mollenhauer, B., Jacob, J., Longerich, S., Del-Aguila, J., Marcus, J., Raghavan, N., Stone, D., Fagboyegun, O., et al. (2023) · npj Parkinson's Disease · doi:10.1038/s41531-023-00461-9 · Cited by 68
Welton, J. L., Brennan, P., Gurney, M., Webber, J. P., Spary, L. K., Carton, D. G., Falcón‐Pérez, J. M., Walton, S. P., Mason, M. D., Tabi, Z., et al. (2016) · Journal of Extracellular Vesicles · doi:10.3402/jev.v5.31209 · Cited by 68
Beyond DNA and RNA: The Expanding Toolbox of Synthetic Genetics
Taylor, A. I., Houlihan, G., & Holliger, P. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a032490 · Cited by 72
Ma, Y., Li, X., Li, W., & Liu, Z. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b14441 · Cited by 66
Subgroups of children with Kawasaki disease: a data-driven cluster analysis
Wang, H., Shimizu, C., Bainto, E. V., Hamilton, S., Jackson, H., Estrada‐Rivadeneyra, D., Kaforou, M., Levin, M., Pancheri, J., Dummer, K., et al. (2023) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(23)00166-9 · Cited by 80
Guo, Y. X., Chen, S.-D., You, J., Huang, S.-Y., Chen, Y., Zhang, Y., Wang, L., He, X., Deng, Y., Zhang, Y.-R., et al. (2024) · Nature Human Behaviour · doi:10.1038/s41562-024-01924-6 · Cited by 78
In vitro selection of BNA (LNA) aptamers
Kuwahara, M., & Obika, S. (2013) · Artificial DNA PNA & XNA · doi:10.4161/adna.25786 · Cited by 62
Aptamers targeting cell surface proteins
Takahashi, M. (2017) · Biochimie · doi:10.1016/j.biochi.2017.11.019 · Cited by 67
Chemical Modifications for a Next Generation of Nucleic Acid Aptamers
Chan, K. Y., Kinghorn, A. B., Hollenstein, M., & Tanner, J. A. (2022) · ChemBioChem · doi:10.1002/cbic.202200006 · Cited by 76
Cheow, L. F., & Han, J. (2011) · Analytical Chemistry · doi:10.1021/ac201307d · Cited by 66
Sensitivity and specificity: twin goals of proteomics assays. Can they be combined?
Wilson, R. (2013) · Expert Review of Proteomics · doi:10.1586/epr.13.7 · Cited by 79
Ren, X., Gelinas, A. D., von Carlowitz, I., Janjić, N., & Pyle, A. M. (2017) · Nature Communications · doi:10.1038/s41467-017-00864-2 · Cited by 76
Proteomics Profiling and Risk of New‐Onset Atrial Fibrillation: Framingham Heart Study
Ko, D., Benson, M. D., Ngo, D., Yang, Q., Larson, M. G., Wang, T. J., Trinquart, L., McManus, D. D., Lubitz, S. A., Ellinor, P. T., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010976 · Cited by 65
Posavi, M., Diaz-Ortiz, M., Liu, B., Swanson, C. R., Skrinak, R. T., Hernandez-Con, P., Amado, D. A., Fullard, M., Rick, J., Siderowf, A., et al. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002931 · Cited by 66
Dressed for success – applying chemistry to modulate aptamer functionality
Tölle, F., & Mayer, G. (2012) · Chemical Science · doi:10.1039/c2sc21510a · Cited by 72
Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer’s disease
Eteleeb, A. M., Novotny, B. C., Tarraga, C. S., Sohn, C., Dhungel, E., Brase, L., Nallapu, A., Buss, J., Farias, F., Bergmann, K., et al. (2024) · PLOS Biology · doi:10.1371/journal.pbio.3002607 · Cited by 64
Proteomics of CKD progression in the chronic renal insufficiency cohort
Dubin, R. F., Deo, R., Ren, Y., Wang, J., Zheng, Z., Shou, H., Go, A. S., Parsa, A., Lash, J. P., Rahman, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41642-7 · Cited by 78
Wang, B., Pozarickij, A., Mazidi, M., Wright, N., Yao, P., Said, S., Iona, A., Kartsonaki, C., Fry, H., Lin, K., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56935-2 · Cited by 64
Oh, S. S., Ahmad, K. M., Cho, M., Kim, S., Xiao, Y., & Soh, H. T. (2011) · Analytical Chemistry · doi:10.1021/ac201269f · Cited by 64
Zyba, S. J., Shenvi, S. V., Killilea, D. W., Holland, T. C., Kim, E., Moy, A., Sutherland, B., Gildengorin, V. L., Shigenaga, M. K., & King, J. C. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.135327 · Cited by 69
O’Dwyer, D. N., Norman, K. C., Xia, M., Huang, Y., Gurczynski, S. J., Ashley, S. L., White, E. S., Flaherty, K. R., Martínez, F. J., Murray, S., et al. (2017) · Scientific Reports · doi:10.1038/srep46560 · Cited by 72
Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs
McArdle, A., Pennington, S. R., & FitzGerald, O. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8630-7 · Cited by 76
Shuken, S. R., Rutledge, J., Iram, T., Losada, P. M., Wilson, E. N., Andreasson, K. I., Leib, R. D., & Wyss‐Coray, T. (2022) · Nature Aging · doi:10.1038/s43587-022-00196-x · Cited by 66
Aptamers as radiopharmaceuticals for nuclear imaging and therapy
Gijs, M., Aerts, A., Impens, N. R. E. N., Baatout, S., & Luxen, A. (2015) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2015.09.005 · Cited by 72
Coenen-Stass, A. M. L., McClorey, G., Manzano, R., Betts, C., Blain, A. M., Saleh, A. F. A., Gait, M. J., Lochmüller, H., Wood, M. J. A., & Roberts, T. C. (2015) · Scientific Reports · doi:10.1038/srep17014 · Cited by 68
Belongie, K., Ferrannini, E., Johnson, K., Andrade‐Gordon, P., Hansen, M. K., & Petrie, J. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182932 · Cited by 70
Beals, J. W., Kayser, B. D., Smith, G. I., Schweitzer, G. G., Kirbach, K., Kearney, M. L., Yoshino, J., Rahman, G., Knight, R. D., Patterson, B. W., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00829-4 · Cited by 77
Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis
Nahid, P., Bliven-Sizemore, E., Jarlsberg, L. G., Groote, M. A. D., Johnson, J. L., Muzanyi, G., Engle, M., WEINER, M. H., Janjić, N., Sterling, D. G., et al. (2014) · Tuberculosis · doi:10.1016/j.tube.2014.01.006 · Cited by 67
Self-citationOpportunities for Sensitive Plasma Proteome Analysis
Landegren, U. D., Vänelid, J., Hammond, M., Nong, R. Y., Wu, D., Ullerås, E., & Kamali‐Moghaddam, M. (2012) · Analytical Chemistry · doi:10.1021/ac2032222 · Cited by 76
Identification of unique proteomic signatures in allergic and non‐allergic skin disease
Wang, J., Suárez‐Fariñas, M., Estrada, Y. D., Parker, M. L., Greenlees, L. M., Stephens, G. L., Krueger, J., Guttman‐Yassky, E., & Howell, M. D. (2017) · Clinical & Experimental Allergy · doi:10.1111/cea.12979 · Cited by 67
Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease
Feldreich, T., Nowak, C., Fall, T., Carlsson, A. C., Carrero, J. J., Ripsweden, J., Qureshi, A. R., Heimbürger, O., Barany, P. F., Stenvinkel, P., et al. (2018) · Journal of Nephrology · doi:10.1007/s40620-018-0556-5 · Cited by 67
“Previous large-scale proteomic efforts in CKD patients are scarce and have primarily utilized urine samples for the proteomics analyses [25–27], with a few exceptions [28].”
BackgroundKimoto, M., Nakamura, M., & Hirao, I. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw619 · Cited by 61
Ali, M., Timsina, J., Western, D., Liu, M., Beric, A., Budde, J., Do, A., Heo, G., Wang, L., Gentsch, J., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.02.014 · Cited by 61
An integrated multi-omics analysis reveals osteokines involved in global regulation
Liang, W., Wei, T., Hu, L., Chen, M., Tong, L., Zhou, W., Duan, X., Zhao, X., Zhou, W., Jiang, Q., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.03.006 · Cited by 67
Molecular Selection, Modification and Development of Therapeutic Oligonucleotide Aptamers
Yu, Y., Liang, C., Lv, Q., Li, D., Xu, X., Liu, B.-Q., Lü, A., & Zhang, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030358 · Cited by 65
Aptamer-based biosensors for the diagnosis of sepsis
Liu, L., Han, Z., An, F., Gong, X., Zhao, C., Zheng, W., Li, M., & Zhou, Q. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00959-5 · Cited by 70
Using the plasma proteome for risk stratifying patients with pulmonary arterial hypertension
Rhodes, C., Wharton, J., Swietlik, E., Harbaum, L., Girerd, B., Coghlan, G., Lordan, J., Church, C., Pepke-Zaba, J., Toshner, M., et al. (2021) · Spiral (Imperial College London) · Cited by 60
Is less more? Lessons from aptamer selection strategies
Szeitner, Z., András, J., Gyurcsányi, R. E., & Mészáros, T. (2014) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2014.04.018 · Cited by 64
Townshend, B., Xiang, J. S., Manzanarez, G., Hayden, E. J., & Smolke, C. D. (2021) · Nature Communications · doi:10.1038/s41467-021-21716-0 · Cited by 69
Farrow, B., Hong, S. A., Romero, E. C., Lai, B. T., Coppock, M. B., Deyle, K. M., Finch, A. S., Stratis‐Cullum, D. N., Agnew, H. D., Yang, S. H., et al. (2013) · ACS Nano · doi:10.1021/nn404296k · Cited by 59
Circulating proteins as predictive and prognostic biomarkers in breast cancer
Veyssière, H., Bidet, Y., Penault-Llorca, F. M., Radosevic‐Robin, N., & Durando, X. (2022) · Clinical Proteomics · doi:10.1186/s12014-022-09362-0 · Cited by 62
Cheng, E. L., Cardle, I. I., Kacherovsky, N. A., Bansia, H., Wang, T., Zhou, Y., Raman, J., Yen, A., Gutierrez, D., Salipante, S. J., et al. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c05349 · Cited by 62
Evolution of Mass Spectrometry Instruments and Techniques for Blood Proteomics
Zhao, Y. C., Xue, Q., Wang, M., Meng, B., Jiang, Y., Zhai, R., Zhang, Y., Dai, X., & Fang, X. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00102 · Cited by 62
Customised nucleic acid libraries for enhanced aptamer selection and performance
Pfeiffer, F., Rosenthal, M., Siegl, J., Ewers, J., & Mayer, G. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.03.026 · Cited by 65
Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne Muscular Dystrophy
Hathout, Y., Chen, L., Ogundele, M., Xu, G., Tawalbeh, S. M., Dang, U. J., Hoffman, E. P., Gordish‐Dressman, H., Conklin, L. S., van den Anker, J. N., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48548-9 · Cited by 63
Wang, L., Nykänen, N.-P., Western, D., Gorijala, P., Timsina, J., Li, F., Wang, Z., Ali, M., Yang, C., Marquié, M., et al. (2023) · doi:10.1101/2023.06.14.23291409 · Cited by 59
Increasing hybridization rate and sensitivity of DNA microarrays using isotachophoresis
Han, C. M., Katilius, E., & Santiago, J. G. (2014) · Lab on a Chip · doi:10.1039/c4lc00374h · Cited by 62
Self-citationWood, G. C., Chu, X., Argyropoulos, G., Benotti, P., Rolston, D., Mirshahi, T., Petrick, A., Gabrielson, J., Carey, D. J., DiStefano, J. K., et al. (2017) · Scientific Reports · doi:10.1038/srep43238 · Cited by 56
Wang, L., Nykänen, N.-P., Western, D., Gorijala, P., Timsina, J., Li, F., Wang, Z., Ali, M., Yang, C., Liu, M., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00687-4 · Cited by 58
“SomaScan is a multiplexed, single-stranded DNA aptamer-based platform from SomaLogic (Boulder, CO) [60].”
BackgroundAptaDiff: de novo design and optimization of aptamers based on diffusion models
Wang, Z., Liu, Z., Zhang, W., Li, Y., Feng, Y., Lv, S., Diao, H., Luo, Z., Yan, P., He, M., et al. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae517 · Cited by 67
Variability of 7K and 11K SomaScan Plasma Proteomics Assays
Candia, J., Fantoni, G., Delgado‐Peraza, F., Shehadeh, N., Tanaka, T., Moaddel, R., Walker, K. A., & Ferrucci, L. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00667 · Cited by 62
Minagawa, H., Onodera, K., Fujita, H., Sakamoto, T., Akitomi, J., Kaneko, N., Shiratori, I., Kuwahara, M., Horii, K., & Waga, I. (2017) · Scientific Reports · doi:10.1038/srep42716 · Cited by 64
Williams, S. A., Murthy, A. C., DeLisle, R. K., Hyde, C., Malarstig, A., Ostroff, R., Weiss, S. J., Segal, M. R., & Ganz, P. (2018) · Circulation · doi:10.1161/circulationaha.117.028213 · Cited by 57
Self-citationThe Impact of the Glomerular Filtration Rate on the Human Plasma Proteome
Christensson, A. G., Ash, J. A., DeLisle, R. K., Gaspar, F. W., Ostroff, R. M., GRUBB, A. O., Lindström, V., Bruun, L., & Williams, S. A. (2018) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201700067 · Cited by 58
Self-citationA neuronal blood marker is associated with mortality in old age
Kaeser, S. A., Lehallier, B., Thinggaard, M., Häsler, L. M., Apel, A., Bergmann, C., Berdnik, D., Jeune, B., Christensen, K., Grönke, S., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00028-4 · Cited by 65
Hirohama, D., Abedini, A., Moon, S., Surapaneni, A., Dillon, S. T., Vassalotti, A., Liu, H., Doke, T., Martinez, V., Dom, Z. I. M., et al. (2023) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000141 · Cited by 64
“73 m(2) (SD) 110 (18) 40 (16) Serum glucose, mg/dl (SD) 105 (22) 142 (28) Histology Glomerulosclerosis, % (SD) 1.”
The Circulating Proteome─Technological Developments, Current Challenges, and Future Trends
Geyer, P. E., Hornburg, D., Pernemalm, M., Hauck, S. M., Palaniappan, K. K., Albrecht, V., Dagley, L. F., Moritz, R. L., Yu, X., Edfors, F., et al. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00586 · Cited by 63
Millward, S. W., Henning, R. K., Kwong, G. A., Pitram, S. M., Agnew, H. D., Deyle, K. M., Nag, A., Hein, J. E., Lee, S. S., Lim, J., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2064389 · Cited by 66
Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia
Mulla, C. M., Goldfine, A. B., Dreyfuss, J. M., Houten, S., Pan, H., Pober, D. M., Wewer Albrechtsen, N. J., Svane, M. S., Schmidt, J. B., Holst, J. J., et al. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03845-0 · Cited by 56
Aguado, B. A., Schuetze, K. B., Grim, J. C., Walker, C. J., Cox, A. C., Ceccato, T. L., Tan, A.-C., Sucharov, C. C., Leinwand, L. A., Taylor, M. R. G., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav3233 · Cited by 55
Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia
Çelik, H., Lindblad, K. E., Popescu, B. O., Gui, G., Goswami, M., Valdez, J., DeStefano, C. B., Lai, C., Thompson, J., Ghannam, J. Y., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019001124 · Cited by 63
Shchukina, I., Bagaitkar, J., Shpynov, O., Loginicheva, E., Porter, S. I., Mogilenko, D. A., Wolin, E., Collins, P. L., Demidov, G. M., Artomov, M., et al. (2020) · Nature Aging · doi:10.1038/s43587-020-00002-6 · Cited by 67
Finkernagel, F., Reinartz, S., Schuldner, M., Malz, A., Jansen, J. M., Wagner, U., Worzfeld, T., Graumann, J., von Strandmann, E. P., & Müller, R. (2019) · Theranostics · doi:10.7150/thno.37549 · Cited by 55
Ideal‐Filter Capillary Electrophoresis (IFCE) Facilitates the One‐Step Selection of Aptamers
Le, A. T. H., Krylova, S. M., Kanoatov, M., Desai, S. P., & Krylov, S. N. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201812974 · Cited by 55
Mapping the serum proteome to neurological diseases using whole genome sequencing
Png, G., Barysenka, A., Repetto, L., Navarro, P., Shen, X., Pietzner, M., Wheeler, E., Wareham, N. J., Langenberg, C., Tsafantakis, E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27387-1 · Cited by 55
Effects of IL-1β inhibition on anemia and clonal hematopoiesis in the randomized CANTOS trial
Woo, J., Lu, D., Lewandowski, A., Xu, H., Serrano, P., Healey, M. L., Yates, D. P., Beste, M. T., Libby, P., Ridker, P. M., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023011578 · Cited by 66
Kumar, S., Mohan, A., Sharma, N. R., Kumar, A., Girdhar, M., Malik, T., & Verma, A. K. (2024) · ACS Omega · doi:10.1021/acsomega.4c02466 · Cited by 64
Tahir, U. A., Katz, D. H., Ávila-Pacheco, J., Bick, A. G., Pampana, A., Robbins, J., Yu, Z., Chen, Z., Benson, M. D., Cruz, D. E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32275-3 · Cited by 56
Dammer, E. B., Shantaraman, A., Ping, L., Duong, D. M., Gerasimov, E. S., Ravindran, S. P., Gudmundsdottir, V., Frick, E. A., Gomez, G. T., Walker, K. A., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adn3504 · Cited by 54
Kivimäki, M., Frank, P., Pentti, J., Jokela, M. M., Nyberg, S. T., Blake, A., Lindbohm, J. V., Oh, H. S., Singh‐Manoux, A., Wyss‐Coray, T., et al. (2025) · The Lancet Digital Health · doi:10.1016/j.landig.2025.01.006 · Cited by 71
Cancer biomarker discovery using DNA aptamers
Jin, C. Y., Qiu, L., Li, J., Fu, T., Zhang, X., & Tan, W. (2015) · The Analyst · doi:10.1039/c5an01918d · Cited by 54
Life's Simple Measures: Unlocking the Proteome
Brody, E., Gold, L., Mehan, M., Ostroff, R., Rohloff, J., Walker, J., & Zichi, D. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.06.021 · Cited by 54
“Because the selection process in each round involves a kinetic challenge with a nonspecific anionic compound, the winning SOMAmers for each selection tend to stay bound to their cognate proteins on kinetic challenge, whereas those “wrong” proteins that were bound during the equilibrium binding steps mostly dissociate…”
InfluentialSelf-citationWhole cell-SELEX of aptamers with a tyrosine-like side chain against live bacteria.
Renders, M., Miller, E., Lam, C. H., & Perrin, D. (2017) · Organic and biomolecular chemistry · doi:10.1039/c6ob02451c · Cited by 41
Molecular‐based diagnosis of multiple sclerosis and its progressive stage
Barbour, C. R., Kosa, P. F., Komori, M., Tanigawa, M., Masvekar, R., Wu, T., Johnson, K. R., Douvaras, P., Fossati, V., Herbst, R., et al. (2017) · Annals of Neurology · doi:10.1002/ana.25083 · Cited by 60
Blanco, C., Bayas, M. V., Yan, F., & Chen, I. A. (2018) · Current Biology · doi:10.1016/j.cub.2018.01.014 · Cited by 61
Click-Particle Display for Base-Modified Aptamer Discovery
Gordon, C. K. L., Wu, D., Pusuluri, A., Feagin, T., Csordas, A. T., Eisenstein, M. S., Hawker, C. J., Niu, J., & Soh, H. T. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00587 · Cited by 58
Tanaka, K., Okuda, T., Kasahara, Y., & Obika, S. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.11.016 · Cited by 59
Yang, C., Fagan, A. M., Perrin, R. J., Rhinn, H., Harari, O., & Cruchaga, C. (2022) · Genome Medicine · doi:10.1186/s13073-022-01140-9 · Cited by 53
Proteomics in the pharmaceutical and biotechnology industry: a look to the next decade
Lill, J. R., Mathews, W. R., Rose, C. M., & Schirle, M. (2021) · Expert Review of Proteomics · doi:10.1080/14789450.2021.1962300 · Cited by 60
Proteomic signatures for identification of impaired glucose tolerance
Carrasco-Zanini, J., Pietzner, M., Lindbohm, J. V., Wheeler, E., Oerton, E., Kerrison, N., Simpson, M., Westacott, M., Drolet, D., Kivimaki, M., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02055-z · Cited by 52
Self-citationProteomic cardiovascular risk assessment in chronic kidney disease
Deo, R., Dubin, R. F., Ren, Y., Murthy, A. C., Wang, J., Zheng, H., Zheng, Z., Feldman, H. I., Shou, H., Coresh, J., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad115 · Cited by 63
Influence of Genetic Variation on Plasma Protein Levels in Older Adults Using a Multi-Analyte Panel
Kim, S., Swaminathan, S., Inlow, M., Risacher, S. L., Nho, K., Shen, L., Foroud, T. M., Petersen, R. C., Aisen, P. S., Soares, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070269 · Cited by 53
Current Implementation And Future of The Athlete Biological Passport
Sottas, P.-E., & Vernec, A. (2012) · Bioanalysis · doi:10.4155/bio.12.130 · Cited by 53
Petek, L. M., Rickard, A. M., Budech, C. B., Poliachik, S. L., Shaw, D., Ferguson, M. R., Tawil, R., Friedman, S. D., & Miller, D. G. (2016) · Neuromuscular Disorders · doi:10.1016/j.nmd.2016.04.012 · Cited by 54
Di Narzo, A. F., Telesco, S. E., Brodmerkel, C., Argmann, C., Peters, L. A., Li, K., Kidd, B., Dudley, J., Cho, J., Schadt, E. E., et al. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1006565 · Cited by 53
Engineering and application of polymerases for synthetic genetics
Houlihan, G., Arangundy‐Franklin, S., & Holliger, P. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.04.004 · Cited by 58
Metadata
- Authors
- Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., Flather, D., Forbes, A., Foreman, T., Fowler, C., Gawande, B., Goss, M., Gunn, M., Gupta, S., Halladay, D., Heil, J., Heilig, J., Hicke, B., Husar, G., Janjic, N., Jarvis, T., Jennings, S., Katilius, E., Keeney, T. R., Kim, N., Koch, T. H., Kraemer, S., Kroiss, L., Le, N., Levine, D., Lindsey, W., Lollo, B., Mayfield, W., Mehan, M., Mehler, R., Nelson, S. K., Nelson, M., Nieuwlandt, D., Nikrad, M., Ochsner, U., Ostroff, R. M., Otis, M., Parker, T., Pietrasiewicz, S., Resnicow, D. I., Rohloff, J., Sanders, G., Sattin, S., Schneider, D., Singer, B., Stanton, M., Sterkel, A., Stewart, A., Stratford, S., Vaught, J. D., Vrkljan, M., Walker, J. J., Watrobka, M., Waugh, S., Weiss, A., Wilcox, S. K., Wolfson, A., Wolk, S. K., Zhang, C., & Zichi, D.
- Affiliations
- University of Colorado Boulder (US)
- SomaLogic (United States) (US)
- Cornell University (US)
- Corresponding author
- Gold, Larry
- Walker, Jeffrey J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-12-07
- Volume
- 5
- Issue
- 12
- Pages
- e15004
- ISSN
- 1756-0357 (ISSN-L)
- 1932-6203
- PMC
- PMC3000457
- OpenAlex
- W2084373725
- Cited by
- 1,754
- References
- 46
- Citations by year
- 2026: 164 · 2025: 190 · 2024: 170 · 2023: 154 · 2022: 184 · 2021: 127 · 2020: 115 · 2019: 105 · 2018: 95 · 2017: 98 · 2016: 78 · 2015: 73 · 2014: 60 · 2013: 56 · 2012: 50
- Type
- posted content
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Nature Precedings (publishedVersion, cc-by)
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Nature Precedings (submittedVersion)
- Funders
- University of Washington
- National Institutes of Health
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- aptamer-based proteomics, biomarker discovery, chemically modified nucleotides, DNA microarrays, plasma protein profiling, chronic kidney disease, multiplexed protein quantification, aptamer selection, disease biomarkers
- MeSH terms
- Aged, Female, Genetic Techniques, Glomerular Filtration Rate, Humans, Kidney Failure, Chronic, Kinetics, Male, Middle Aged, Nucleic Acid Hybridization, Mass Spectrometry, Reproducibility of Results, Biomarkers, Gene Library, Evidence-Based Medicine, Oligonucleotide Array Sequence Analysis, Proteome, Proteomics, Aptamers, Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.